|
|
|
Volumn 48, Issue 2, 2007, Pages 169-
|
|
The cost of bringing a radiopharmaceutical to the patient's bedside
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM;
THALLIUM;
COST;
DRUG APPROVAL;
EUROPE;
HEALTH CARE QUALITY;
HUMAN;
MARKET;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
REIMBURSEMENT;
RISK REDUCTION;
TAX;
UNITED STATES;
ARTICLE;
DRUG INDUSTRY;
ECONOMICS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RESEARCH;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DRUG INDUSTRY;
RADIOPHARMACEUTICALS;
RESEARCH;
|
|
EID: 34047216162
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
